Nanopiezoelectric 3D-Bioprinted Neural Organoid Models Epileptic Neuron-Microglia Circuit in Neurodegeneration.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41877549.
- Also identified by DOI 10.1021/acs.nanolett.5c06156.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Epilepsy is increasingly linked to neurodegeneration, yet the cellular drivers of the neuron-microglia interplay remain unclear. Herein, we present "EpiNeuroid", a 3D-bioprinted human neural organoid that incorporates barium titanate piezoelectric nanoparticles to generate an on-demand, ultrasound-triggered electrostimulatory microenvironment that induces a hyperexcitable state, recapitulating key electrophysiological signatures indicative of a trend toward epileptiform discharges. EpiNeuroid recapitulates neuronal DAMPs release (HMGB1, TLR4, NF-κB), microglial activation (Iba1, TNF-α, IL-1β, IL-6, iNOS), heightened neuronal Ca<sup>2+</sup> influx, and progressive viability loss, with microglia amplifying injury and hyperexcitability to establish a self-perpetuating epilepsy-neurodegeneration loop. To enable therapeutic screening, we engineered self-assembled ginsenoside protopanaxadiol nanorods (PPD-NRs), which outperformed free protopanaxadiol by suppressing BDNF/ERK/CREB/mTOR hyperactivation, reducing cytokines and HMGB1, restoring Ca<sup>2+</sup> homeostasis, and preserving neurosphere integrity. Collectively, EpiNeuroid provides a human-relevant, tunable platform for the mechanistic dissection and discovery of nanotherapeutic interventions in epilepsy-associated neurodegeneration.
Medical subject headings
- Microglia
- Neurons
- Epilepsy
- Organoids